Study of Prognostic Factors in Patients Admitted to ICU for Stroke

Stroke Clinical Trial

— REAVC  

Official title:

Study of Prognostic Factors in Patients Admitted to ICU for Stroke

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04434287
• Other study ID #: REAVC ( 29BRC20.0062)
• Status: Completed
• Start date: June 12, 2020
• Est. completion date: June 29, 2020

Study information

• Verified date: April 2020
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Outcome of stroke patients admitted to the intensive care unit the intensive care unit (ICU) is poor and haemorrhagic stroke, fixed dilated pupil(s) and GCS <10 are associated with increased mortality and poor functional outcome. However little is known about the impact of clinical events occuring during the ICU stay (ventilator acquired pneumoniae, shock, dysglycemia....).

The objective of this study was to determine the mortality rate and the functional outcomes of stroke patients admitted to ICU and to identify predictors of poor outcome in this population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 204
• Est. completion date: June 29, 2020
• Est. primary completion date: June 29, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• acute stroke

• ICU admission for acute stroke

• 1 organ dysfunction : coma, shock, respiratory failure

Exclusion Criteria:

• refuse participation

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill
• Stroke

Locations

Country	Name	City	State
France	CHRU de Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality		through ICU hospitalization, an average of one month
Secondary	Mortality	Mortality	At 90 days
Secondary	Functional outcome: Modified Rankin Score	Modified Rankin Score (0: no symptoms at all; 6: dead)	at hospitalization discharge, an average of three months